NEOPLASM MALIGNANT

Clinical trials for NEOPLASM MALIGNANT explained in plain language.

Never miss a new study

Get alerted when new NEOPLASM MALIGNANT trials appear

Sign up with your email to follow new studies for NEOPLASM MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1 Completed 1 Terminated 3

New Antibody-Drug conjugate STRO-002 tested in advanced cancers

Disease control Completed

This study tested a new drug called STRO-002 in 19 Chinese adults with advanced ovarian, endometrial, or other solid tumors that had not responded to prior treatments. STRO-002 is an antibody-drug conjugate, meaning it combines a targeted antibody with a chemotherapy drug to deli…

Matched conditions: NEOPLASM MALIGNANT

Phase: PHASE1, PHASE2 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

NEOPLASM MALIGNANT

Get alerted when new NEOPLASM MALIGNANT trials appear

New Antibody-Drug conjugate STRO-002 tested in advanced cancers